Axogen Ebitda vs Total Revenue Analysis

AXGN Stock

USD 13.34 0.24 1.83%

Axogen financial indicator trend analysis is way more than just evaluating Axogen Inc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Axogen Inc is a good investment. Please check the relationship between Axogen Ebitda and its Total Revenue accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

Ebitda vs Total Revenue

Ebitda vs Total Revenue Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Axogen Inc Ebitda account and Total Revenue. At this time, the significance of the direction appears to have pay attention.

The correlation between Axogen's Ebitda and Total Revenue is -0.71. Overlapping area represents the amount of variation of Ebitda that can explain the historical movement of Total Revenue in the same time period over historical financial statements of Axogen Inc, assuming nothing else is changed. The correlation between historical values of Axogen's Ebitda and Total Revenue is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebitda of Axogen Inc are associated (or correlated) with its Total Revenue. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Revenue has no effect on the direction of Ebitda i.e., Axogen's Ebitda and Total Revenue go up and down completely randomly.

Correlation Coefficient

-0.71

Relationship Direction	Negative
Relationship Strength	Weak

View All Relationships

Ebitda

Total Revenue

Total revenue comprises all receipts Axogen Inc generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Most indicators from Axogen's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Axogen Inc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

At this time, Axogen's Selling General Administrative is very stable compared to the past year. As of the 24th of November 2024, Sales General And Administrative To Revenue is likely to grow to 0.36, though Enterprise Value Over EBITDA is likely to grow to (23.17).

	2021	2022	2023	2024 (projected)
Interest Expense	1.4M	624K	2.8M	1.6M
Depreciation And Amortization	4.7M	4.9M	5.6M	5.8M

Interest Expense Depreciation And Amortization

Axogen fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Other Current Assets	Accounts Payable	Common Stock Total Equity	Common Stock
Total Assets		0.64	0.98	0.94	0.93	0.86	0.4	-0.94	0.68	0.85	-0.69	0.69	0.96	0.89	0.71	0.94	0.99	0.82	0.84	0.9	-0.37	0.85	0.88	0.84	0.89	0.88
Short Long Term Debt Total	0.64		0.7	0.69	0.33	0.84	0.83	-0.78	0.49	0.84	-0.76	0.05	0.67	0.63	0.97	0.71	0.64	0.94	0.84	0.32	0.08	0.8	0.82	0.63	0.66	0.62
Other Current Liab	0.98	0.7		0.97	0.86	0.9	0.46	-0.94	0.71	0.9	-0.72	0.58	0.96	0.86	0.77	0.95	0.96	0.87	0.9	0.82	-0.35	0.89	0.93	0.86	0.87	0.85
Total Current Liabilities	0.94	0.69	0.97		0.82	0.9	0.44	-0.96	0.74	0.89	-0.75	0.5	0.98	0.91	0.75	0.97	0.96	0.87	0.89	0.77	-0.35	0.91	0.87	0.94	0.92	0.9
Total Stockholder Equity	0.93	0.33	0.86	0.82		0.63	0.08	-0.78	0.62	0.63	-0.47	0.86	0.85	0.82	0.4	0.8	0.91	0.55	0.62	0.97	-0.42	0.64	0.68	0.72	0.8	0.81
Property Plant And Equipment Net	0.86	0.84	0.9	0.9	0.63		0.76	-0.9	0.47	1.0	-0.9	0.22	0.89	0.72	0.91	0.93	0.85	0.96	1.0	0.54	-0.29	0.98	0.92	0.87	0.75	0.7
Net Debt	0.4	0.83	0.46	0.44	0.08	0.76		-0.53	-0.02	0.76	-0.79	-0.25	0.42	0.27	0.87	0.52	0.38	0.79	0.75	0.01	0.0	0.69	0.65	0.44	0.3	0.25
Retained Earnings	-0.94	-0.78	-0.94	-0.96	-0.78	-0.9	-0.53		-0.69	-0.9	0.79	-0.49	-0.97	-0.93	-0.81	-0.97	-0.97	-0.9	-0.9	-0.76	0.2	-0.92	-0.86	-0.92	-0.95	-0.92
Cash	0.68	0.49	0.71	0.74	0.62	0.47	-0.02	-0.69		0.46	-0.22	0.59	0.69	0.81	0.47	0.63	0.7	0.57	0.47	0.7	-0.16	0.51	0.61	0.59	0.81	0.81
Non Current Assets Total	0.85	0.84	0.9	0.89	0.63	1.0	0.76	-0.9	0.46		-0.9	0.21	0.88	0.71	0.91	0.93	0.84	0.95	1.0	0.53	-0.29	0.98	0.92	0.87	0.74	0.69
Non Currrent Assets Other	-0.69	-0.76	-0.72	-0.75	-0.47	-0.9	-0.79	0.79	-0.22	-0.9		-0.05	-0.75	-0.59	-0.81	-0.83	-0.71	-0.84	-0.9	-0.35	0.23	-0.9	-0.7	-0.81	-0.62	-0.57
Cash And Short Term Investments	0.69	0.05	0.58	0.5	0.86	0.22	-0.25	-0.49	0.59	0.21	-0.05		0.54	0.65	0.09	0.45	0.66	0.22	0.2	0.93	-0.28	0.21	0.4	0.32	0.59	0.66
Net Receivables	0.96	0.67	0.96	0.98	0.85	0.89	0.42	-0.97	0.69	0.88	-0.75	0.54		0.93	0.72	0.98	0.98	0.84	0.88	0.8	-0.32	0.91	0.84	0.94	0.94	0.91
Common Stock Shares Outstanding	0.89	0.63	0.86	0.91	0.82	0.72	0.27	-0.93	0.81	0.71	-0.59	0.65	0.93		0.64	0.88	0.94	0.75	0.71	0.85	-0.13	0.75	0.72	0.83	0.99	0.99
Non Current Liabilities Total	0.71	0.97	0.77	0.75	0.4	0.91	0.87	-0.81	0.47	0.91	-0.81	0.09	0.72	0.64		0.77	0.69	0.98	0.91	0.38	-0.08	0.86	0.89	0.68	0.66	0.62
Inventory	0.94	0.71	0.95	0.97	0.8	0.93	0.52	-0.97	0.63	0.93	-0.83	0.45	0.98	0.88	0.77		0.96	0.87	0.93	0.73	-0.32	0.96	0.84	0.96	0.9	0.86
Other Stockholder Equity	0.99	0.64	0.96	0.96	0.91	0.85	0.38	-0.97	0.7	0.84	-0.71	0.66	0.98	0.94	0.69	0.96		0.81	0.84	0.88	-0.31	0.87	0.84	0.9	0.94	0.93
Total Liab	0.82	0.94	0.87	0.87	0.55	0.96	0.79	-0.9	0.57	0.95	-0.84	0.22	0.84	0.75	0.98	0.87	0.81		0.95	0.52	-0.17	0.92	0.93	0.79	0.78	0.74
Property Plant And Equipment Gross	0.84	0.84	0.9	0.89	0.62	1.0	0.75	-0.9	0.47	1.0	-0.9	0.2	0.88	0.71	0.91	0.93	0.84	0.95		0.52	-0.29	0.98	0.91	0.88	0.75	0.69
Total Current Assets	0.9	0.32	0.82	0.77	0.97	0.54	0.01	-0.76	0.7	0.53	-0.35	0.93	0.8	0.85	0.38	0.73	0.88	0.52	0.52		-0.34	0.54	0.64	0.63	0.81	0.84
Short Term Debt	-0.37	0.08	-0.35	-0.35	-0.42	-0.29	0.0	0.2	-0.16	-0.29	0.23	-0.28	-0.32	-0.13	-0.08	-0.32	-0.31	-0.17	-0.29	-0.34		-0.29	-0.3	-0.31	-0.12	-0.11
Intangible Assets	0.85	0.8	0.89	0.91	0.64	0.98	0.69	-0.92	0.51	0.98	-0.9	0.21	0.91	0.75	0.86	0.96	0.87	0.92	0.98	0.54	-0.29		0.87	0.93	0.8	0.74
Other Current Assets	0.88	0.82	0.93	0.87	0.68	0.92	0.65	-0.86	0.61	0.92	-0.7	0.4	0.84	0.72	0.89	0.84	0.84	0.93	0.91	0.64	-0.3	0.87		0.74	0.74	0.71
Accounts Payable	0.84	0.63	0.86	0.94	0.72	0.87	0.44	-0.92	0.59	0.87	-0.81	0.32	0.94	0.83	0.68	0.96	0.9	0.79	0.88	0.63	-0.31	0.93	0.74		0.87	0.82
Common Stock Total Equity	0.89	0.66	0.87	0.92	0.8	0.75	0.3	-0.95	0.81	0.74	-0.62	0.59	0.94	0.99	0.66	0.9	0.94	0.78	0.75	0.81	-0.12	0.8	0.74	0.87		0.99
Common Stock	0.88	0.62	0.85	0.9	0.81	0.7	0.25	-0.92	0.81	0.69	-0.57	0.66	0.91	0.99	0.62	0.86	0.93	0.74	0.69	0.84	-0.11	0.74	0.71	0.82	0.99

Click cells to compare fundamentals

Axogen Account Relationship Matchups

Axogen fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	154.6M	201.4M	208.0M	195.4M	196.8M	206.7M
Short Long Term Debt Total	3.3M	53.8M	67.5M	67.4M	69.3M	72.8M
Other Current Liab	10.9M	16.5M	16.5M	13.5M	17.1M	18.0M
Total Current Liabilities	20.9M	22.8M	24.3M	23.8M	30.4M	32.0M
Total Stockholder Equity	132.2M	123.1M	112.6M	101.0M	95.7M	100.4M
Property Plant And Equipment Net	18.1M	54.1M	78.1M	93.7M	104.3M	109.5M
Net Debt	(32.4M)	5.0M	34.7M	52.1M	32.3M	33.9M
Retained Earnings	(179.9M)	(203.6M)	(230.6M)	(259.6M)	(281.3M)	(267.2M)
Cash	35.7M	48.8M	32.8M	15.3M	37.0M	38.9M
Non Current Assets Total	19.6M	56.1M	81.0M	97.3M	108.8M	114.3M
Non Currrent Assets Other	(19.6M)	15.7M	(81.0M)	(97.3M)	(87.6M)	(83.2M)
Cash And Short Term Investments	96.5M	104.0M	84.1M	48.8M	37.0M	20.0M
Net Receivables	16.9M	17.6M	18.2M	22.2M	25.1M	26.4M
Common Stock Shares Outstanding	39.2M	40.0M	41.2M	42.1M	42.9M	45.0M
Liabilities And Stockholders Equity	154.6M	201.4M	208.0M	195.4M	196.8M	206.7M
Non Current Liabilities Total	1.6M	55.4M	71.2M	70.6M	70.7M	74.3M
Inventory	13.9M	12.5M	16.7M	18.9M	23.0M	24.2M
Other Stockholder Equity	311.6M	326.4M	342.8M	360.2M	376.5M	395.4M
Total Liab	22.5M	78.2M	95.5M	94.4M	101.2M	106.2M
Property Plant And Equipment Gross	18.1M	54.1M	85.7M	93.7M	118.0M	123.9M
Total Current Assets	135.0M	145.3M	127.0M	98.1M	88.0M	92.4M
Short Term Debt	1.7M	1.7M	1.8M	1.3M	1.5M	1.5M
Intangible Assets	1.5M	2.1M	2.9M	3.6M	4.5M	4.8M
Other Current Assets	1.7M	11.1M	8.1M	8.2M	8.8M	9.3M
Accounts Payable	8.3M	4.6M	5.9M	9.0M	11.8M	12.4M
Common Stock Total Equity	396K	406K	417K	424K	487.6K	512.0K
Common Stock	396K	406K	417K	424K	431K	452.6K
Other Liab	164K	112K	15K	3K	2.7K	2.6K
Property Plant Equipment	18.1M	38.4M	78.1M	93.7M	107.7M	113.1M
Net Tangible Assets	130.6M	121.1M	109.7M	97.4M	112.0M	58.6M
Long Term Debt	1.6M	52.9M	65.6M	66.1M	46.6M	33.6M
Long Term Debt Total	30K	52.9M	65.6M	66.1M	76.0M	79.8M
Capital Surpluse	311.6M	326.4M	342.8M	360.2M	414.2M	210.4M
Short Long Term Debt	4.7M	28K	1.7M	863K	776.7K	737.9K

Pair Trading with Axogen

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Axogen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Axogen will appreciate offsetting losses from the drop in the long position's value.

Moving against Axogen Stock

0.39	IVP	Inspire Veterinary	Pair Corr
0.33	ENOV	Enovis Corp	Pair Corr

The ability to find closely correlated positions to Axogen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Axogen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Axogen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Axogen Inc to buy it.

The correlation of Axogen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Axogen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Axogen Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Axogen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Axogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Axogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Axogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Axogen Inc Stock:

How To Invest In Axogen

Details

Is Axogen Stock a good investment?

Details

What is Axogen's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Axogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Axogen. If investors know Axogen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Axogen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.33)

Revenue Per Share

4.16

Quarterly Revenue Growth

0.179

Return On Assets

(0.03)

Return On Equity

(0.15)

The market value of Axogen Inc is measured differently than its book value, which is the value of Axogen that is recorded on the company's balance sheet. Investors also form their own opinion of Axogen's value that differs from its market value or its book value, called intrinsic value, which is Axogen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Axogen's market value can be influenced by many factors that don't directly affect Axogen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Axogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Axogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Axogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Axogen Ebitda vs Total Revenue Analysis

Ebitda vs Total Revenue

Ebitda vs Total Revenue Correlation Analysis

Correlation Coefficient

Ebitda

Total Revenue

Axogen fundamental ratios Correlations

Axogen Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Axogen fundamental ratios Accounts

Pair Trading with Axogen

Moving against Axogen Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 1.0	Non Current Assets Total
Other Stockholder Equity	+ 0.99	Total Assets
Common Stock Total Equity	+ 0.99	Common Stock Shares Outstanding
Common Stock	+ 0.99	Common Stock Shares Outstanding

Other Stockholder Equity	- 0.97	Retained Earnings
Inventory	- 0.97	Retained Earnings
Net Receivables	- 0.97	Retained Earnings
Retained Earnings	- 0.96	Total Current Liabilities
Common Stock Total Equity	- 0.95	Retained Earnings
Retained Earnings	- 0.94	Other Current Liab